Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Confusing guidance [Regulatives / Guidelines]

posted by nobody – 2019-09-25 13:36 (731 d 20:14 ago) – Posting: # 20648
Views: 3,430

imho the authority wants you to be AWARE that there is a (reversible? during plasma preparation? storage? under chromatographic conditions?) glucuronidation relevant for the compound. Did you have a look at the PAR or alike for PK details?

—
Kindest regards, nobody

Complete thread:

Ezetimibe BE Mutasim 2019-09-23 14:40 [Regulatives / Guidelines]
- Ezetimibe BE Helmut 2019-09-23 15:36
- Confusing guidance Helmut 2019-09-25 11:52
  - Confusing guidancenobody 2019-09-25 13:36
- Ezetimibe final guidance Helmut 2019-09-28 12:11
  - Ezetimibe final guidance Ohlbe 2019-09-30 11:03
    - Ezetimibe final guidance Helmut 2019-09-30 15:33
- Ezetimibe BE ElMaestro 2019-09-30 13:12
  - Ezetimibe BE Helmut 2019-09-30 15:26

Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: Sunday 09:50 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable. Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz